SLC22A23 Inhibitors

SLC22A23 Inhibitors target various aspects of solute transport and cellular metabolism, influencing the functional context of SLC22A23. Given SLC22A23's classification as a solute carrier, modulation of ion and solute transport processes could indirectly impact its activity. Inhibitors of organic anion transporters like Probenecid, as well as compounds like Cimetidine and Quinidine, which are known to interact with drug transporters, could indirectly affect the transport activity of SLC22A23. Diuretics such as Furosemide and Amiloride, which modulate ion transport, might influence processes where SLC22A23 is involved.

Compounds affecting cellular metabolism or ion homeostasis, such as Metformin, Omeprazole, and Chloroquine, could also have implications for SLC22A23's function. Additionally, chemicals like Losartan, Atorvastatin, and 12β-Hydroxydigitoxin, which interact with various transporters or affect ion gradients, might indirectly influence SLC22A23. These compounds, while not directly targeting SLC22A23, are important for exploring the complex processes of solute transport, ion homeostasis, and cellular metabolism.